The global ligases enzyme market size stood at around $367.4 million in 2021, and it will grow at a CAGR of 6.2% during 2021–2030, to reach $631.7 million by 2030.
The global downstream processing market revenue was valued at $21.1 billion in 2021, which is projected to advance at a CAGR of 10.3% during 2021–2030, to reach $51.0 billion by 2030.
The global microarray analysis market size stood at around $3,846.7 million in 2021, and it will grow at a CAGR of 9.9% during 2021–2030, to reach $9,011.1 million.
The global epigenetics market size in 2021 was $1,563.8 million, and it is expected to advance at a CAGR of 17.1% during 2021–2030, to reach $6,460.5 million by 2030.
The global RNA analysis market is predicted to value $14,909.8 million in 2030, growing from $4,833.4 million in 2021 at a CAGR of 13.3% during 2021–2030.
The DNA extraction kit market size stood at $1,354.4 million in 2021, and it is expected to grow at a compound annual growth rate of 8.5% during 2021–2030, to reach $2,818.2 million by 2030.
The pharmacogenomics market size was around $5,527.2 million in 2021, and it is set to grow at a 7.4% CAGR during 2021–2030.
The AI in genomics market was valued at an estimated $519.0 million in 2021, and it is expected to advance at a CAGR of 49.7% during 2021-2030.
The global agricultural biotechnology market was valued at $39,565.6 million in 2020, which is expected to grow at a CAGR of 10.7% during the forecast period (2021–2030).
The global protein A resin market generated an estimated revenue of $486.4 million in 2019, which is projected to reach $1,020.7 million by 2030, witnessing a CAGR of 7.0% during 2019–2030.
The global catalog peptides market generated $238.4 million revenue in 2018 and is projected to advance at a CAGR of 5.8% during the forecast period.
The global skin replacement and substitutes market generated $838.0 million revenue in 2018. The market is expected to grow with a CAGR of 6.3% during the forecast period, mainly on account of increasing cases of burns, rising inclination of consumers to spend on appearance, and increasing incidence of skin diseases, across the globe.
The biobanking market size was $25.8 billion in 2018, and it is expected to grow at a CAGR of 6.2% during 2019–2024 owing to the rising incidence of chronic diseases and increasing number of genomic research activities for studying them.
The global plasma fractionation market size is projected to witness significant growth in the coming years. This is due to the rising geriatric population that is prone to several rare diseases which require the utilization of plasma derivatives.
The customized peptide synthesis market revenue stood at $268.8 million in 2018, and the market is predicted to advance at a CAGR of 6.4% between 2019 and 2024.
In the coming years, the global 3D printing in medical applications market size is projected to grow significantly due to the emerging trend of patient-specific products, technological advancements, and increasing support from government as well as private organizations.
The global cell and tissue culture supplies market is expected to witness considerable growth during the forecast period on account of advanced applications of cell and tissue culture equipment and consumables in the life science research activities. Moreover, the requisition of optimal environment to conduct cell and tissue related research activities requires customized supplies which increases their demand in the life science industry.
The global immunoassay instruments market is expected to witness considerable growth during the forecast period, mainly due to the rising prevalence of chronic and infectious diseases around the globe. Immunoassay is a laboratory based diagnostic procedure, that is performed using an immunological reaction of antibodies.
Globally, the pharmaceutical membrane technology market is projected to showcase notable growth during the forecast period, mainly due to increasing pharmaceutical production, rising research and development (R&D) activities, and growing demand for generic drugs in the developing nations.
The global animal vaccines market size is expected to grow substantially in the coming years. This is majorly ascribed to the rising adoption of companion animals across the world, due to which vaccination has become mandatory for these animals since they suffer from different diseases.
The global protein extracts from single cell protein sources market generated $5.3 billion revenue in 2017 and is projected to witness a CAGR of 8.6% during the forecast period, on account of the rising initiatives to create awareness about health and environmental benefits of alternative protein sources, rise in the production of animal feed, and increasing initiatives by public and private entities to cater the increasing demand for protein.
The global oligonucleotide synthesis market generated $1.5 billion revenue in 2017 and is projected to advance at a CAGR of 10.8% during 2018–2023. The market is mainly driven by increasing research activities in synthetic biology, rising prevalence of cancer and infectious diseases, advancements in oligonucleotide synthesis technologies, and favorable government regulations.
Valued at $4.6 billion in 2017, the global cell isolation market is expected to generate $12.6 billion revenue by 2023, witnessing a CAGR of 18.8% during the forecast period (2018–2023).
In 2017, the global molecular cytogenetics market was valued at $1.8 billion, and it is expected to grow at a CAGR of 9.9% during the forecast period (2018–2023).
The global laboratory filtration market valued $2.3 billion in 2017 and is projected to advance at a CAGR of 7.3% during 2018–2023. The usage of filtration products in the food and beverage industry and the introduction of technologically advanced products are the major factors driving the market growth. Filtration media, filtration assemblies, and filtration accessories are the key products available in the market.
Saudi Arabian microbiology cell culture market is estimated to be valued at $29.8 million in 2017 and is projected to grow at a CAGR of 4.5% during the forecast period. Based on product, the market has been categorized into consumables and instruments. Instruments are further classified into bioreactors, cell culture vessels, cell culture storage equipment and cell culture supporting equipment.
global organ-on-chip market size was valued at $11.0 million in 2017. It is expected to grow at a CAGR of 40.1% during the forecast period. On the basis of offering, services held a larger share in the global organ-on-chip market in 2017.
The global metabolomics market is projected to achieve a lucrative growth rate during the forecast period due to the increased government and private funding in research and development, and rise in metabolic application in personalized medication.
The global DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2023).
The global genetic testing market size is expected to register a considerable growth in the near future because of the increasing demand for direct-to-consumer genetic testing, wide applications of genetic testing in genetic diseases and oncology, technological advancements and availability of new tests, and rising demand for personalized medicine.
The global cancer/tumor profiling market size was $25.8 billion in 2016, and it is expected to grow at a CAGR of 19.0% in the forecast period (2017–2023).
In 2016, the global protein expression market was valued at $1.4 billion; the market is further projected to reach $3.0 billion by 2023, growing at a CAGR of 11.7% during the forecast period (2017–2023).
Protein assays are utilized in life science research to detect the presence of protein in a sample. Estimation of protein fixation is important for protein cleaning, electrophoresis, cell science, atomic science, and research applications. Although there are a wide variety of protein assays available, none of the assays can be used without first considering their suitability for an application. Each assay has its own advantages and limitations and often it is necessary to obtain more
Blood plasma product is the extracted portion from the blood using fractionation process to deliver products rich in plasma proteins. These products are used as body fluids, antibodies and clotting factors in medical industries that aid in treatment of chronic ailments like auto-immune disorders and haemophilia. The global blood plasma product market is expected to witness a significant growth during the forecast period due to the high demand by a large pool of patients
Stem cells are the cells that have the potential to differentiate into various types of cells in the body. Embryonic stem cells and adult stem cells are the two main types of stem cells. Stem cells could possibly be used to generate cells and tissues for therapy of a variety of diseases including Alzheimer's disease, Parkinson's disease, heart disease, spinal cord injury, diabetes, and arthritis. The global stem cell banking market is expected to grow due to the increasing prevalence of such diseases and increasing a
Valued at $13.7 billion in 2016, the global pharmaceutical filtration market is projected to reach $27.7 billion by 2023, witnessing a CAGR of 10.6% during the forecast period.
Feed enzymes are enhancer that are incorporated in the animal feed during the manufacturing process to resolve the nutrient deficiencies in farm animals. Sometimes, animals face digestive troubles due to the consumption of anti-nutritional ingredients in the feed, which can be avoided by addition of feed enzymes. The feed enzymes are not only capable of withstanding acidic condition but also the heat generated during the pelleting process that breakdown starch, making the feed more digestible. With the global rise in demand
Cell-based assays are commonly used analytical tools to measure the cell proliferation, viability, cytotoxicity, production and screening of compounds. Owing to the rise in cases of chronic disorders and increasing inclination of the government organizations and private firms funding in the health sector, there has been a consistent high demand of new therapeutic drug discovery. In this regard, the cell-based assays have advantage over the conventional animal based models for drug discovery. Cell-based assays utilizes live c
The blood group typing market size is predicted to witness massive growth in the coming years, because of the surging utilization of the process in forensic sciences and prenatal testing, increasing number of accident and trauma victims, resulting in a rising number of blood transfusions, and surging requirement for blood and derivatives.
The global high-throughput screening market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure, increasing research and development activities, launch of technologically advanced products that are miniaturized and automated and growing popularity of high-throughput screening for drug discovery. Moreover, high adoption of high-throughput screening models in pharmaceutical and biotechnology
The global orthobiologics market would experience significant growth in the coming years, driven by the increasing number of road accident and sports injury victims, rising obesity incidence, surging awareness about the issue, and booming geriatric population.
The global microbial identification market is expected to attain a value of $1.4 billion by 2022, witnessing a CAGR of 6.0% during the forecast period (2016–2022).
The global DNA diagnostics market is growing due to technological advancement, and cost effective diagnostic solution. The growing adoption of new technologies such as polymerase chain reaction, next generation sequencing, and microarray is also posing an opportunity for the global market. Among the various products, the instrument segment leads the market, due to
The global synthetic biology market size is projected to reach $23.8 billion by 2020, growing at a CAGR of 35.4% during the forecast period. The market is growing due to the increasing support from government organizations, growing geriatric population and innovative and advanced applications of synthetic biology.
Rising demand of disposables in biopharmaceutical production, increasing prevalence of chronic diseases, which requires biological drugs for their management and treatment, low manufacturing costs of disposable products and instrument, and improving life science research infrastructure are some of the growth drivers of the global single-use bioprocessing systems
The global biophotonics market is growing significantly due to advancement in optical technology, high incidences of chronic diseases, and increasing demand for minimally invasive surgeries. The massive unexplored biophotonics market in the emerging economies and large number of non-medical applications of biophotonics are creating ample opportunities for the
The global autologous stem cell and non-stem cell based therapy market is growing significantly due to high incidences of cancer and cardiovascular diseases, and presence of large number of patients requiring transplantation. The lack of service providers in the autologous stem cell market, and the massive unexplored
The global peptide therapeutics market is growing significantly due to the increasing prevalence of cardiovascular diseases and cancer, advances in peptide therapeutics manufacturing technology, and increasing healthcare expenditure. In addition, growing research and development activities along with a rich peptide therapeutics pipeline is expected to support the growth of the
The global forensic technologies market is growing significantly due to increasing rate of crime across the globe, technological advancements in forensic techniques, and increasing number of forensic laboratories. In addition, increasing demand and awareness for DNA testing are supporting growth of global forensic technologies market. Outsourcing of crime cases by
The global cell analysis market is growing significantly due to increasing prevalence of chronic and infectious diseases, increasing research and development activities and technological advancements in cell analysis techniques. In addition, increasing usage of cell analysis in various applications, such as target identification and validation, cell identification and
The global next-generation sequencing (NGS) market size is projected to grow substantially in the coming years. The market is growing due to the favorable regulatory scenario in North America, rising research & development activities in regions including Europe and North America, technological advancements in next generation sequencing in developed countries, rising utilization of the NGS technology by biopharmaceutical & pharmaceutical companies in developing countries.
The global next-generation antibody therapeutics market is expected to generate revenue of $11.9 billion by 2020, progressing at a CAGR of 44.0% during the forecast period (2015 to 2020).
A biological marker, commonly known as a biomarker, measures and evaluates biological and pathogenic processes. It also measures pharmacological responses to a therapeutic intervention. Biomarkers are used in predictions, cause, diagnosis, progression, regression and outcome of various diseases. Biomarkers can be specific cell, molecules, genes, gene products,
In the coming years, the global companion diagnostics market size is projected to register a considerable growth rate. This is attributed to the growing demand for personalized medicine, wide application areas of companion diagnostics, increasing need for targeted therapy, rising incidences of cancer, discovery of new biomarkers for different conditions, and growing requirement for next-generation sequencing (NGS).